Cargando…
Current and upcoming radionuclide therapies in the direction of precision oncology: A narrative review
As new molecular tracers are identified to target specific receptors, tissue, and tumor types, opportunities arise for the development of both diagnostic tracers and their therapeutic counterparts, termed “theranostics.” While diagnostic tracers utilize positron emitters or gamma-emitting radionucli...
Autores principales: | Shah, Hina J., Ruppell, Evan, Bokhari, Rozan, Aland, Parag, Lele, Vikram R., Ge, Connie, McIntosh, Lacey J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918751/ https://www.ncbi.nlm.nih.gov/pubmed/36785643 http://dx.doi.org/10.1016/j.ejro.2023.100477 |
Ejemplares similares
-
Incidental detection of a tumour on 68-Gallium DOTANOC PET/CT
por: Shah, Hina J., et al.
Publicado: (2014) -
Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
por: Shah, Hina J., et al.
Publicado: (2017) -
Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer – a narrative review
por: Szponar, Paweł, et al.
Publicado: (2023) -
Update on radionuclide therapy in oncology
por: Nitipir, Cornelia, et al.
Publicado: (2017) -
Upcoming conferences
Publicado: (2009)